Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Obesity 5Polycystic Ovary Syndrome 3Overweight 1Neoplasms 1Metabolic Syndrome 1Inflammation 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Dyslipidemias 1

Interventions

Resistance Training 4Nutrition Assessment 4naloxegol 3Surveys and Questionnaires 3Exercise 3alvimopan 2Therapeutics 2Psychiatric Rehabilitation 2Oxygen 2Nutritional Status 2Mouthwashes 2Morphine 2Ketamine 2Interviews as Topic 2Fibroblast Growth Factor 7 2Counseling 2semaglutide 1naldemedine 1methylnaltrexone 1ma zi ren wan 1kang-lai-te 1hydrated silica gel-based toothpaste 1golotimod 1dexamethasone acetate 1dexamethasone 21-phosphate 1calcium phosphate 1auricularum 1aluminum hydroxide, magnesium hydroxide, drug combination 1Weights and Measures 1Walking 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × semaglutide × Other × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡